Central Phoenix Surgical Center Adds Progenitor Cell Therapy
Central Phoenix Surgical Center has received approval from various regulatory bodies to add Progenitor Cell Therapy to its list of interventional pain services.
Progenitor Cell Proteins are used by orthopedic surgeons to stimulate bone repair post-surgery. Physicians at Central Phoenix Surgical Center take a minimally invasive approach to injecting the protein directly into the damaged joint to stimulate repair and start the regenerative process.
Progenitor cells are designed to repair damage of structures within articular joints and patients with degenerative conditions are good candidates for the therapy. The procedure is done in Central Phoenix Surgical Center's AAAHC accredited and Medicare-certified facility.
More Articles on Pain Management:
Tennessee Grants 255 Pain Clinics Licenses Since New Law
Indiana Senator to Sponsor Bill Requiring Pain Clinic Owners be Physicians
Pain Specialist Dr. Jack Berndt Joins Pinnacle Pain Center
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
- PriorityOne to Expand Team in 2014, Move to Bigger Office Location
- BayCare Ambulatory Surgery Center to Begin Expansion Project
- Albany Urology Clinic & Surgical Center Opens in New Location
- Greater Miami Chamber of Commerce Names Nueterra Global Alliance Best New Business
- Weill Cornell Researchers Link Controlled Breathing to IBD Symptom Relief